These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 17496166

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. N,N'-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors.
    Nie H, Widdowson KL, Palovich MR, Fu W, Elliott JD, Bryan DL, Burman M, Schmidt DB, Foley JJ, Sarau HM, Busch-Petersen J.
    Bioorg Med Chem Lett; 2006 Nov 01; 16(21):5513-6. PubMed ID: 16934456
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2.
    Ramirez BL, Howard OM, Dong HF, Edamatsu T, Gao P, Hartlein M, Kron M.
    J Infect Dis; 2006 Apr 15; 193(8):1164-71. PubMed ID: 16544258
    [Abstract] [Full Text] [Related]

  • 46. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
    Feniger-Barish R, Ran M, Zaslaver A, Ben-Baruch A.
    Cytokine; 1999 Dec 15; 11(12):996-1009. PubMed ID: 10623425
    [Abstract] [Full Text] [Related]

  • 47. The functional significance behind expressing two IL-8 receptor types on PMN.
    Stillie R, Farooq SM, Gordon JR, Stadnyk AW.
    J Leukoc Biol; 2009 Sep 15; 86(3):529-43. PubMed ID: 19564575
    [Abstract] [Full Text] [Related]

  • 48. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA, Sharma A, de Nardin E.
    Cytokine; 2000 Oct 15; 12(10):1480-8. PubMed ID: 11023662
    [Abstract] [Full Text] [Related]

  • 49. Reversing systemic inflammatory response syndrome with chemokine receptor pepducins.
    Kaneider NC, Agarwal A, Leger AJ, Kuliopulos A.
    Nat Med; 2005 Jun 15; 11(6):661-5. PubMed ID: 15880119
    [Abstract] [Full Text] [Related]

  • 50. Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists.
    Liu S, Liu Y, Wang H, Ding Y, Wu H, Dong J, Wong A, Chen SH, Li G, Chan M, Sawyer N, Gervais FG, Henault M, Kargman S, Bedard LL, Han Y, Friesen R, Lobell RB, Stout DM.
    Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5741-5. PubMed ID: 19713110
    [Abstract] [Full Text] [Related]

  • 51. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
    Navarro J.
    Biochemistry; 2019 Mar 12; 58(10):1432-1439. PubMed ID: 30726064
    [Abstract] [Full Text] [Related]

  • 52. The CXCR1 tail mediates beta1 integrin-dependent cell migration via MAP kinase signaling.
    Liu-Bryan R, Pay S, Schraufstatter IU, Rose DM.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):117-25. PubMed ID: 15896307
    [Abstract] [Full Text] [Related]

  • 53. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
    Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM.
    J Immunol; 2012 Sep 15; 189(6):2824-32. PubMed ID: 22869904
    [Abstract] [Full Text] [Related]

  • 54. The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects.
    Todd CM, Salter BM, Murphy DM, Watson RM, Howie KJ, Milot J, Sadeh J, Boulet LP, O'Byrne PM, Gauvreau GM.
    Pulm Pharmacol Ther; 2016 Dec 15; 41():34-39. PubMed ID: 27640067
    [Abstract] [Full Text] [Related]

  • 55. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha.
    Asagoe K, Yamamoto K, Takahashi A, Suzuki K, Maeda A, Nohgawa M, Harakawa N, Takano K, Mukaida N, Matsushima K, Okuma M, Sasada M.
    J Immunol; 1998 May 01; 160(9):4518-25. PubMed ID: 9574558
    [Abstract] [Full Text] [Related]

  • 56. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR, Li F, Zhang X, Wang W, Zhao X, Nayyar A.
    J Leukoc Biol; 2005 Dec 01; 78(6):1265-72. PubMed ID: 16204619
    [Abstract] [Full Text] [Related]

  • 57. Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.
    Maeda DY, Quinn MT, Schepetkin IA, Kirpotina LN, Zebala JA.
    J Pharmacol Exp Ther; 2010 Jan 01; 332(1):145-52. PubMed ID: 19779130
    [Abstract] [Full Text] [Related]

  • 58. Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha.
    Hall DA, Beresford IJ, Browning C, Giles H.
    Br J Pharmacol; 1999 Feb 01; 126(3):810-8. PubMed ID: 10188995
    [Abstract] [Full Text] [Related]

  • 59. Expression of zebrafish cxcl8 (interleukin-8) and its receptors during development and in response to immune stimulation.
    Oehlers SH, Flores MV, Hall CJ, O'Toole R, Swift S, Crosier KE, Crosier PS.
    Dev Comp Immunol; 2010 Mar 01; 34(3):352-9. PubMed ID: 19941893
    [Abstract] [Full Text] [Related]

  • 60. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
    Braber S, Overbeek SA, Koelink PJ, Henricks PA, Zaman GJ, Garssen J, Kraneveld AD, Folkerts G.
    Eur J Pharmacol; 2011 Oct 15; 668(3):443-9. PubMed ID: 21458445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.